Search research articles
Contact Us
Filters
Showing results (761-770 of 869) with videos related to
Page
of 87
Sort By:
Plos One
|
September 3, 2015
Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials
Yunda Huang, Dean Follmann, Martha Nason, et al.
Journal of AIDS & Clinical Research
|
November 21, 2015
Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals
Jonathan D Fuchs, Pierre-Alexandre Bart, Nicole Frahm, et al.
Nature Communications
|
June 17, 2023
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration
Dean Follmann, Meagan P O'Brien, Jonathan Fintzi, et al.
Clinical and Vaccine Immunology : CVI
|
September 22, 2017
DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8<sup>+</sup> T-Cell Responses by Interleukin-12 Plasmid DNA
Shuying S Li, Nidhi K Kochar, Marnie Elizaga, et al.
The Lancet. Infectious Diseases
|
July 22, 2024
Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial
Glenda E Gray, Kathryn Mngadi, Ludo Lavreys, et al.
The Journal of Infectious Diseases
|
July 28, 2012
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E
Supachai Rerks-Ngarm, Robert M Paris, Supamit Chunsutthiwat, et al.
NPJ Vaccines
|
January 17, 2026
Association between COVID-19 vaccine efficacy and epidemic force of infection
Jing Xu, M Elizabeth Halloran, Mia Moore, et al.
The Journal of Infectious Diseases
|
February 16, 2017
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial
Holly E Janes, Kristen W Cohen, Nicole Frahm, et al.
PLOS Global Public Health
|
April 11, 2025
ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost
Leigh H Fisher, Erica Lazarus, Chenchen Yu, et al.
Plos One
|
May 12, 2017
Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women
Peter B Gilbert, Jean-Louis Excler, Georgia D Tomaras, et al.
Page
of 87
Search research articles
Search
Showing results (761-770 of 869) with videos related to
Sort By:
Page
of 87
Plos One
|
September 3, 2015
Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials
Yunda Huang, Dean Follmann, Martha Nason, et al.
Journal of AIDS & Clinical Research
|
November 21, 2015
Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals
Jonathan D Fuchs, Pierre-Alexandre Bart, Nicole Frahm, et al.
Nature Communications
|
June 17, 2023
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration
Dean Follmann, Meagan P O'Brien, Jonathan Fintzi, et al.
Clinical and Vaccine Immunology : CVI
|
September 22, 2017
DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8<sup>+</sup> T-Cell Responses by Interleukin-12 Plasmid DNA
Shuying S Li, Nidhi K Kochar, Marnie Elizaga, et al.
The Lancet. Infectious Diseases
|
July 22, 2024
Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial
Glenda E Gray, Kathryn Mngadi, Ludo Lavreys, et al.
The Journal of Infectious Diseases
|
July 28, 2012
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E
Supachai Rerks-Ngarm, Robert M Paris, Supamit Chunsutthiwat, et al.
NPJ Vaccines
|
January 17, 2026
Association between COVID-19 vaccine efficacy and epidemic force of infection
Jing Xu, M Elizabeth Halloran, Mia Moore, et al.
The Journal of Infectious Diseases
|
February 16, 2017
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial
Holly E Janes, Kristen W Cohen, Nicole Frahm, et al.
PLOS Global Public Health
|
April 11, 2025
ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost
Leigh H Fisher, Erica Lazarus, Chenchen Yu, et al.
Plos One
|
May 12, 2017
Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women
Peter B Gilbert, Jean-Louis Excler, Georgia D Tomaras, et al.
Page
of 87